Significant Ownership of BCLS II Investco, LP

Signature - Title
/s/ Adam Koppel - Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BCLS II Investco, LP.

Notify me when BCLS II Investco, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BCLS II Investco, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares, nominal value Euro 0.12 per share 4.7% $214,462,841 -$241,180,844 5,376,356 -53% BCLS Fund III Investments, LP 02 Dec 2025

Schedules 13D/G Reported by BCLS II Investco, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.